By Kelly Knaub ( February 2, 2015, 2:06 PM EST) -- Ranbaxy Inc. and AstraZeneca PLC on Friday blasted the plaintiffs' request for a new trial in an antitrust action that accused the drugmakers of using a patent settlement to delay the launch of a cheaper generic version of heartburn treatment Nexium, saying a new trial is not warranted....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.